November 2026
Largest Diagnostics & Genomics Public Companies in India
Benchmark revenue and EBITDA valuation multiples for public comps like
Molbio Diagnostics, Metropolis Healthcare, Thyrocare Technologies, Lord's Mark Industries and Genomic Valley Biotech.
 | Molbio Diagnostics makes portable molecular diagnostic devices and test kits, sold as Truenat, for infections such as tuberculosis, COVID-19 and others. Customers are public health programmes, hospitals and laboratories in India and abroad. Headquartered in Goa. | $14 | -- | $1.6B | $1.6B | 10.5x | 46.6x | ||
| Metropolis Healthcare runs pathology laboratories and collection centres offering routine and specialised tests. Customers are patients, doctors and hospitals. It is one of the larger Indian diagnostic chains. Headquartered in Mumbai. | $6 | +9% | $1.2B | $1.2B | 6.9x | 27.4x | ||
| Diagnostics firm running large central labs that process blood and other tests, mostly for partner labs, hospitals and collection centres. Also sells direct to consumers through a digital channel. Based in Mumbai. | $5 | -9% | $801M | $749M | 8.6x | 26.2x | ||
| Lord's Mark Industries is a diversified manufacturer with a range of products across packaging, healthcare consumables and diagnostics (including in-vitro diagnostic kits). Customers are industrial and healthcare buyers. Headquartered in Mumbai. | $1 | +4457% | $325M | $348M | 4.8x | 39.9x | ||
| Genomic Valley Biotech is a listed Indian biotechnology company whose shares trade on the BSE. It was set up to carry out biotechnology research and to produce tissue-cultured plants, and it has been involved in commercial greenhouse cultivation of crops and in operating a plant tissue culture laboratory. The registered office is in the Bahadurgarh area of Jhajjar district, Haryana. The company has been adding human genomics activities, including next-generation sequencing based diagnostic services, oncology diagnostics, decision-support for doctors and personalised therapy options, and research process outsourcing services for researchers. Its income comes from horticultural and agricultural products and from diagnostic and research services. The business is small, with a promoter-led shareholder base and a modest public float. | $1 | -- | $2M | $2M | 54.8x | 335.2x | ||
| Median | $5 | +9% | $801M | $749M | 8.6x | 39.9x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.